OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the NLRP3 inflammasome in cancer
Maryam Moossavi, Negin Parsamanesh, Afsane Bahrami, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 365

Showing 26-50 of 365 citing articles:

Plant NLR immunity activation and execution: a biochemical perspective
Federica Locci, Jane E. Parker
Open Biology (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer
Journal of the American Heart Association (2020) Vol. 9, Iss. 2
Open Access | Times Cited: 131

NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Fernando Janczur Velloso, Marina Trombetta-Lima, Valesca Anschau, et al.
Bioscience Reports (2019) Vol. 39, Iss. 4
Open Access | Times Cited: 119

Cysteine Cathepsins in Tumor-Associated Immune Cells
Tanja Jakoš, Anja Pišlar, Anahid Jewett, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 110

Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
Hassan Yousefi, Ladan Mashouri, Samuel C. Okpechi, et al.
Biochemical Pharmacology (2020) Vol. 183, pp. 114296-114296
Open Access | Times Cited: 101

Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome
Roberto De Luca, Paul J. Davis, Hung‐Yun Lin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 97

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Jin Kyung Seok, Han Chang Kang, Yong‐Yeon Cho, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 16-35
Open Access | Times Cited: 88

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
Carolina Pellegrini, Matteo Fornai, Luca Antonioli, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2876-2876
Open Access | Times Cited: 87

Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
Connie Wong, Jason Baum, Angela Silvestro, et al.
Cancer Research (2020) Vol. 80, Iss. 24, pp. 5597-5605
Open Access | Times Cited: 80

NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
Fei Lu, Yanan Zhao, Yihua Pang, et al.
Cancer Letters (2020) Vol. 497, pp. 178-189
Open Access | Times Cited: 80

Breast Cancer Cell–Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production
Jeong‐Hoon Jang, Do-Hee Kim, Jae Min Lim, et al.
Cancer Research (2020) Vol. 80, Iss. 6, pp. 1342-1356
Open Access | Times Cited: 78

The role of the microbiome and the NLRP3 inflammasome in the gut and lung
Chantal Donovan, Gang Liu, Sj Shen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 3, pp. 925-935
Closed Access | Times Cited: 77

Epigenetic Mechanisms of Inflammasome Regulation
Giulia Poli, Consuelo Fabi, Marina Maria Bellet, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5758-5758
Open Access | Times Cited: 74

27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression
Liqian Ma, Lawrence Wang, Adam Nelson, et al.
Cancer Letters (2020) Vol. 493, pp. 266-283
Open Access | Times Cited: 72

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
Sonia Missiroli, Mariasole Perrone, Caterina Boncompagni, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 70

The Role of Decorin and Biglycan Signaling in Tumorigenesis
Valentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 62

The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
Rongrong Bai, Yue Lang, Jie Shao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110181-175909142110181
Open Access | Times Cited: 61

Retinal microglia: Functions and diseases
Wei Fan, Weidi Huang, Jiayi Chen, et al.
Immunology (2022) Vol. 166, Iss. 3, pp. 268-286
Open Access | Times Cited: 61

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway
Xiao Li, Xue Li, Peilin Cao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 61

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Sally A. Clayton, Lucy MacDonald, Mariola Kurowska‐Stolarska, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59

Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
Liwen Ren, Li Wan, Xiangjin Zheng, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 1, pp. 194-208
Open Access | Times Cited: 58

Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation
Hsin‐Chung Lin, Yu-Jen Chen, Yau–Huei Wei, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57

Scroll to top